User profiles for Rosana Quintana

Rosana Quintana

MD, MSc, PhD
Verified email at reumatologia.org.ar
Cited by 1076

Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)

…, GB Harvey, D Wojdyla, GJ Pons-Estel, R Quintana… - RMD open, 2020 - rmdopen.bmj.com
Aim A decrease in proteinuria has been considered protective from renal damage in lupus
nephritis (LN), but a cut-off point has yet to be established. The aim of this study was to …

[PDF][PDF] Estudio de dos variantes de la puntuación de riesgo nutricional" NUTRIC" en pacientes criticos ventilados

…, CJ Settecase, MB Quaglino, R Quintana - Nutrición …, 2014 - SciELO Espana
Introducción: La puntuación NUTRIC, propuesta para eva-luar el riesgo de eventos adversos
potencialmente modificables por la intervención nutricional en pacientes críticos, utiliza un …

El anciano dependiente y el desgaste físico y psíquico de su cuidador

NS Domínguez, RG Caballo, RL Quintana… - Revista Española de …, 2006 - Elsevier
Introducción se describen las características clínicas, funcionales y socioeconómicas de un
grupo de pacientes que precisan atención para cuidados domiciliarios. Se evalúa la …

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …

…, CA Isnardi, R Quintana… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo …

…, D Gómez-Martín, RR Sevrini, RM Quintana… - Annals of the …, 2018 - ard.bmj.com
Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease,
represents a significant challenge for both diagnosis and treatment. Patients with SLE in …

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a …

…, SLE Ribeiro, M Pinheiro, R Quintana… - The Lancet …, 2021 - thelancet.com
Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …

[HTML][HTML] Características epidemiológicas y desenlaces de la infección por SARS-CoV-2 en pacientes con patologías reumáticas: primer reporte del registro argentino …

CA Isnardi, G Gómez, R Quintana… - Revista argentina de …, 2021 - SciELO Argentina
Con el fin de evaluar el impacto de la infección por SARS-CoV-2 en pacientes con enfermedades
reumáticas, la Sociedad Argentina de Reumatología desarrolló el Registro Nacional …

[HTML][HTML] Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina

R Quintana, AMR Silvestre, M Goñi, V García… - Clinical …, 2016 - Springer
This study aimed to estimate the prevalence of musculoskeletal disorders and rheumatic
diseases among the indigenous Qom (Toba) population in the city of Rosario, Santa Fe, …

Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem

I Peláez-Ballestas, Y Granados, R Quintana… - Annals of the …, 2018 - ard.bmj.com
Epidemiological studies in Latin America suggest indigenous people lack proper healthcare
for musculoskeletal (MSK) and rheumatic diseases. Objectives This study aimed to estimate …

[HTML][HTML] Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry

…, V Saurit, I Petkovic, RM Báez, R Quintana… - Clinical …, 2023 - Springer
Background/objective This study aims to describe the course and to identify poor prognostic
factors of SARS-CoV-2 infection in patients with rheumatic diseases. Methods Patients ≥ 18 …